SGLT2 inhibition in the management of type 2 diabetes: Potential impact on CVD Risk - PACE-CME

SGLT inhibition in the management of type diabetes Potential impact on CVD Risk

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

SBP target of lower than 120 mmHg reduces risk of CV events in T2DM
SBP target of lower than 120 mmHg reduces risk of CV events in T2DM
AHA 2024
SBP target of lower than 120 mmHg reduces risk of CV events in T2DM
- Shawna Nesbitt, MD
Definition and staging of CKM syndrome
Definition and staging of CKM syndrome
MinuteCE®
Definition and staging of CKM syndrome
1.00 program credit
- Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
1.00 program credit
Screening for CKM syndrome
Screening for CKM syndrome
MinuteCE®
Screening for CKM syndrome
1.00 program credit
- Jürgen Floege, MD
1.00 program credit
MinuteCE®
Optimizing care for patients with CKM syndrome: a multidisciplinary approach
1.00 credit 4 episodes
- Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
- Jürgen Floege, MD
- Muthiah Vaduganathan, MD, MPH
1.00 credit 4 episodes